Medical experts discuss how the Inflation Reduction Act’s out-of-pocket prescription drug cost cap, effective in 2025, may impact access to oral chemotherapy options for metastatic colorectal cancer.
Source link
mCRC Treatment Access: IRA Cost Cap Impact and Final Insights
